
The Hippocampus in Patients Treated With Electroconvulsive Therapy
A Proton Magnetic Resonance Spectroscopic Imaging Study
Gabriele Ende, PhD;
Dieter F. Braus, MD;
Sigrid Walter, MSc;
Wolfgang Weber-Fahr, MSc;
Fritz A. Henn, MD, PhD
Arch Gen Psychiatry. 2000;57:937-943.
Background We monitored the effect of electroconvulsive therapy (ECT) on the nuclear magnetic resonancedetectable metabolites N-acetylaspartate, creatine and phosphocreatine, and choline-containing compounds in the hippocampus by means of hydrogen 1 magnetic resonance spectroscopic imaging. We hypothesized that if ECT-induced memory deterioration was associated with neuronal loss in the hippocampus, the N-acetylaspartate signal would decrease after ECT and any increased membrane turnover would result in an increase in the signal from choline-containing compounds.
Methods Seventeen patients received complete courses of ECT, during which repeated proton magnetic resonance spectroscopic imaging studies of the hippocampal region were performed. Individual changes during the course of ECT were compared with values obtained in 24 healthy control subjects and 6 patients remitted from major depression without ECT.
Results No changes in the hippocampal N-acetylaspartate signals were detected after ECT. A significant mean increase of 16% of the signal from choline-containing compounds after 5 or more ECT treatments was observed. Despite the mostly unilateral ECT application (14 of 17 patients), the increase in the choline-containing compound signal was observed bilaterally. Lactate or elevated lipid signals were not detected. All patients showed clinical amelioration of depression after ECT.
Conclusions Electroconvulsive therapy is not likely to induce hippocampal atrophy or cell death, which would be reflected by a decrease in the N-acetylaspartate signal. Compared with an age-matched control group, the choline-containing compounds signal in patients with a major depressive episode was significantly lower than normal, before ECT and normalized during ECT.
From Nuclear Magnetic Resonance Research in Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Specific hippocampal choline decrease in an animal model of depression
HONG et al.
Br. J. Radiol. 2009;82:549-553.
ABSTRACT
| FULL TEXT
Brain Metabolic Alterations in Medication-Free Patients With Bipolar Disorder
Dager et al.
Arch Gen Psychiatry 2004;61:450-458.
ABSTRACT
| FULL TEXT
Low-Grade Gliomas and Focal Cortical Developmental Malformations: Differentiation with Proton MR Spectroscopy
Vuori et al.
Radiology 2004;230:703-708.
ABSTRACT
| FULL TEXT
Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors
Newton et al.
J. Neurosci. 2003;23:10841-10851.
ABSTRACT
| FULL TEXT
The neuropathology of primary mood disorder
Harrison
Brain 2002;125:1428-1449.
ABSTRACT
| FULL TEXT
Lower Concentration of Thalamic N-Acetylaspartate in Patients With Schizophrenia: A Replication Study
Ende et al.
Am. J. Psychiatry 2001;158:1314-1316.
ABSTRACT
| FULL TEXT
Electroconvulsive Therapy: Time to Bring It Out of the Shadows
Glass
JAMA 2001;285:1346-1348.
FULL TEXT
ECT Does Not Increase Hippocampal Neuronal Loss
JWatch Psychiatry 2000;2000:3-3.
FULL TEXT
|